Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
NCT00926952
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Actinic Keratosis
Interventions
DRUG:
Methylaminolevulinate (Metvix, Metvixia)
DEVICE:
Photodynamic Therapy (Aktilite)
Sponsor
Innovaderm Research Inc.
Collaborators
[object Object]